Miami, Florida, United States
Responsible for managing a portfolio of accounts with a focus on achieving RxCrossroads by McKesson’s business development strategy of identifying, designing and pulling through new business growth opportunities.
Provide field reimbursement services in New York and Western Pennsylvania. Ensure that the appropriate patients have access to UCB products and services. Responsible for partnering with Rheumatology and Gastroenterology health care professionals; providing payer specific guidance on appropriateness of codes and patient policy coverage within all sites of administration through the buy and bill model.
Develop distribution strategies for UCB’s biologics portfolio through multiple channels including: Specialty Pharmacy (SPP) In-Office-Administration, Home Infusion and Hospitals. Create and deliver value added patient services (PAP, Co-pay, Case Management and Home Health Nurse) that are aligned with the strategies of the Cimzia brand.
Developed strategies, initiatives, programs and materials for the field based reimbursement team designed to meet the needs of the marketplace.
Promoted the Multiple Sclerosis immunotherapy Rebif (injectible) and the oncology therapy Novantrone (IV). Account management included thought leader development and product positioning in institutional and outpatient based accounts.
Managed institutional and outpatient accounts with the objective of maximizing Risperdal and Risperdal Consta (injectible) utilization. Marketed Risperdal and Risperdal Consta to Psychiatrists, Pharmacists, and Emergency Department personnel. • Ranked #1 territory in District and # 2 territory in Region 2004 (YTD) • Ranked #1 territory in District 2003, 2001, 2000